Abstract |
Using the C57BL/6→(C57BL/6 x DBA/2)F(1)-hybrid model of acute graft-versus-host disease (GVHD), we previously showed that treating the donor mice with palifermin provides protection from morbidity and a shift from Th1 to Th2 cytokine production. To determine whether thymic stromal lymphopoietin (TSLP) is involved in palifermin-mediated immune modulation, we used donors from the following groups: (1) untreated wild-type donors, (2) palifermin-treated wild-type donors, (3) untreated TSLPR(-/-) donors, and (4) palifermin-treated TSLPR(-/-) donors. Survival in the recipients was 0%, 100%, 31%, and 0%, for groups 1-4, respectively, indicating that TSLP responsiveness is required for palifermin-mediated protection from GVHD. We also found that the increases in Th2 cytokine levels that are induced by palifermin treatment are obviated in TSLPR(-/-) donors, and that protection from GVHD (group 2) is associated with a higher percentage of CD4(+)CD25(+)Foxp3(+) cells in the graft. Collectively, our findings show that when palifermin and TSLP act in concert, the predominant effect is protection in this model.
|
Authors | Cynthia A Ellison, Yuriy V Lissitsyn, Juliet A Packiasamy, Warren J Leonard, John G Gartner |
Journal | Journal of clinical immunology
(J Clin Immunol)
Vol. 31
Issue 3
Pg. 406-13
(Jun 2011)
ISSN: 1573-2592 [Electronic] Netherlands |
PMID | 21161346
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cytokines
- Fibroblast Growth Factor 7
- Thymic Stromal Lymphopoietin
- TSLP protein, mouse
|
Topics |
- Animals
- Cytokines
(deficiency, genetics, metabolism)
- Disease Models, Animal
- Female
- Fibroblast Growth Factor 7
(pharmacology)
- Flow Cytometry
- Gene Deletion
- Graft vs Host Disease
(immunology, physiopathology, prevention & control)
- Injections, Subcutaneous
- Lymphocyte Transfusion
- Lymphocytes
(immunology, metabolism)
- Mice
- Mice, Inbred C57BL
- Mice, Inbred DBA
- Mice, Knockout
- Th1-Th2 Balance
(drug effects)
- Transplantation, Homologous
- Thymic Stromal Lymphopoietin
|